Skip to main content

Table 2 The Odds ratio of metabolic syndrome components for the prevalence of CKD

From: The association of metabolic syndrome components and chronic kidney disease in patients with hypertension

 Model 1Model 2Model 3
 OR (95% CI)pOR (95% CI)pOR (95% CI)p
Hypertension grades1.10
(1.00–1.22)
0.061.15
(1.04–1.28)
0.011.20
(1.00–1.44)
0.05
Elevated TG1.43
(1.11–1.83)
0.011.63
(1.26–2.11)
< 0.011.81
(1.28–2.57)
0.01
Reduced HDL-C1.13
(0.88–1.46)
0.351.07
(0.82–1.39)
0.640.79
(0.55–1.14)
0.21
Elevated FBG1.85
(1.37–2.49)
< 0.011.83
(1.36–2.47)
< 0.011.43
(1.00–2.07)
0.05
Elevated waist circumference1.40
(1.15–1.69)
< 0.011.31
(1.07–1.59)
0.011.28
(0.90–1.82)
0.17
  1. Model 1: unadjusted OR; Model 2: OR adjusted for age and gender; Model 3: OR adjusted for age, gender, antihypertensive therapy, statin therapy. FBG: Fasting blood glucose; HDL-C: High density lipoprotein-C; TG: Triglycerides